Your browser doesn't support javascript.
loading
No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled, cross-over trial (ENERGIZE).
Rajeev, Surya Panicker; Roberts, Carl Alexander; Brown, Emily; Sprung, Victoria S; Harrold, Jo A; Halford, Jason C G; Stancak, Andrej; Boyland, Emma J; Kemp, Graham J; Perry, Julie; Howarth, Elaine; Jackson, Richard; Wiemken, Andrew; Schwab, Richard; Cuthbertson, Daniel J; Wilding, John P H.
Afiliação
  • Rajeev SP; Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
  • Roberts CA; Liverpool University Hospitals NHS Foundation Trust, University Hospital Aintree, Liverpool, UK.
  • Brown E; Department of Psychology, Institute of Population Health, University of Liverpool, Liverpool, UK.
  • Sprung VS; Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
  • Harrold JA; Liverpool University Hospitals NHS Foundation Trust, University Hospital Aintree, Liverpool, UK.
  • Halford JCG; Liverpool University Hospitals NHS Foundation Trust, University Hospital Aintree, Liverpool, UK.
  • Stancak A; Research Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK.
  • Boyland EJ; Department of Psychology, Institute of Population Health, University of Liverpool, Liverpool, UK.
  • Kemp GJ; School of Psychology, University of Leeds, Leeds, UK.
  • Perry J; Department of Psychology, Institute of Population Health, University of Liverpool, Liverpool, UK.
  • Howarth E; Department of Psychology, Institute of Population Health, University of Liverpool, Liverpool, UK.
  • Jackson R; Department of Musculoskeletal and Ageing Science, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
  • Wiemken A; Liverpool Clinical Trials Centre (LCTC), University of Liverpool, Liverpool, UK.
  • Schwab R; Liverpool Clinical Trials Centre (LCTC), University of Liverpool, Liverpool, UK.
  • Cuthbertson DJ; Liverpool Clinical Trials Centre (LCTC), University of Liverpool, Liverpool, UK.
  • Wilding JPH; Division of Sleep Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Diabetes Obes Metab ; 25(12): 3621-3631, 2023 12.
Article em En | MEDLINE | ID: mdl-37667658
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2023 Tipo de documento: Article